These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 7575015

  • 1. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE, Vorob'ev PA, Dvoretskiĭ LI, Izotova GN, Miagkov AV, Shvyreva GS, Iakovlev SV.
    Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
    [Abstract] [Full Text] [Related]

  • 2. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 3. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A, Fillastre JP, Humbert G.
    Antimicrob Agents Chemother; 1990 Jan 06; 34(1):17-20. PubMed ID: 2327756
    [Abstract] [Full Text] [Related]

  • 4. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG, Saltvedt E, Walstad RA, Marstein S.
    Am J Med; 1992 Apr 06; 92(4A):38S-40S. PubMed ID: 1316068
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec 06; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic study of sparfloxacin in patients receiving regular hemodialysis].
    Aoki N, Kouda Y, Yoshikawa H, Usuda Y.
    Jpn J Antibiot; 1995 Aug 06; 48(8):999-1002. PubMed ID: 7474327
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D, Gaudin C, Benhamou JP.
    Am J Med; 1992 Apr 06; 92(4A):41S-44S. PubMed ID: 1316069
    [Abstract] [Full Text] [Related]

  • 8. Lomefloxacin clinical pharmacokinetics.
    Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.
    Clin Pharmacokinet; 1993 Jul 06; 25(1):6-19. PubMed ID: 8394795
    [Abstract] [Full Text] [Related]

  • 9. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1998 Jul 06; 43(10):46-52. PubMed ID: 9825111
    [No Abstract] [Full Text] [Related]

  • 10. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM, Hoepelman AI, Smit JM, Sips PA, Rozenberg-Arska M, Glerum JH, Verhoef J.
    Antimicrob Agents Chemother; 1992 Nov 06; 36(11):2458-61. PubMed ID: 1336948
    [Abstract] [Full Text] [Related]

  • 11. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994 Nov 06; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct 06; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 13. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV.
    Urologiia; 2002 Oct 06; (1):11-4. PubMed ID: 11877963
    [Abstract] [Full Text] [Related]

  • 14. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT, Nix DE.
    Clin Pharm; 1992 Sep 06; 11(9):753-66. PubMed ID: 1325892
    [Abstract] [Full Text] [Related]

  • 15. [Cardiac valve prosthesis in patients with infective endocarditis and chronic renal insufficiency in terminal stage on a programmable hemodialysis].
    Todurov BM, Mironiuk AI, Zograb'ian RO, Kuzmich IN, Goncharenko NV.
    Klin Khir; 2004 Feb 06; (2):26-8. PubMed ID: 15124470
    [Abstract] [Full Text] [Related]

  • 16. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T, Fujimura A, Harada K, Sunaga K, Ohmori M, Sakamoto K.
    Eur J Clin Pharmacol; 1996 Feb 06; 51(1):95-8. PubMed ID: 8880059
    [Abstract] [Full Text] [Related]

  • 17. The role of lomefloxacin in the treatment of chronic prostatitis.
    Scelzi S, Travaglini F, Nerozzi S, Dominici A, Ponchietti R, Novelli A, Rizzo M.
    J Chemother; 2001 Feb 06; 13(1):82-7. PubMed ID: 11233805
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M, Matera MG, Tufano MA, Catalanotti P, Polverino M, Cantoni V, Fici F, Sarlo F, Rossi F.
    J Chemother; 2001 Aug 06; 13(4):407-12. PubMed ID: 11589484
    [Abstract] [Full Text] [Related]

  • 19. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E, Muller-Serieys C, Kafé H.
    Am J Med; 1992 Apr 06; 92(4A):8S-11S. PubMed ID: 1316076
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of rufloxacin in patients with impaired renal function.
    Perry G, Mant TG, Morrison PJ, Sacks S, Woodcook J, Wise R, Imbimbo BP.
    Antimicrob Agents Chemother; 1993 Apr 06; 37(4):637-41. PubMed ID: 8388194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.